{
"NDC": {
"NDCCode": "38739-600-02",
"PackageDescription": "2 SYRINGE in 1 CONTAINER (38739-600-02) > .5 mL in 1 SYRINGE",
"NDC11Code": "38739-0600-02",
"ProductNDC": "38739-600",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Zimhi",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Naloxone Hydrochloride",
"DosageFormName": "INJECTION, SOLUTION",
"RouteName": "INTRAMUSCULAR; SUBCUTANEOUS",
"StartMarketingDate": "20220115",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA212854",
"LabelerName": "Adamis Pharmaceuticals",
"SubstanceName": "NALOXONE HYDROCHLORIDE",
"StrengthNumber": "5",
"StrengthUnit": "mg/.5mL",
"Pharm_Classes": "Opioid Antagonist [EPC], Opioid Antagonists [MoA]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2022-03-16",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20221231",
"StartMarketingDatePackage": "20220115",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}